IRIS
MIGLIACCIO, Antimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.580
NA - Nord America 5.549
AS - Asia 4.446
SA - Sud America 575
AF - Africa 51
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.216
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 5.876
US - Stati Uniti d'America 5.470
SG - Singapore 1.401
IE - Irlanda 1.019
CN - Cina 962
IT - Italia 820
HK - Hong Kong 623
UA - Ucraina 488
BR - Brasile 486
VN - Vietnam 462
GB - Regno Unito 444
DE - Germania 300
TR - Turchia 298
IN - India 278
KR - Corea 200
FI - Finlandia 193
SE - Svezia 123
FR - Francia 85
GR - Grecia 81
JP - Giappone 79
BE - Belgio 44
CA - Canada 43
AR - Argentina 36
BD - Bangladesh 27
NL - Olanda 22
MX - Messico 21
ID - Indonesia 18
IQ - Iraq 15
PK - Pakistan 15
PL - Polonia 14
AT - Austria 13
EC - Ecuador 13
ZA - Sudafrica 13
ES - Italia 12
VE - Venezuela 11
JO - Giordania 10
IR - Iran 8
MA - Marocco 8
PY - Paraguay 8
CO - Colombia 7
EG - Egitto 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
PH - Filippine 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CL - Cile 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
KE - Kenya 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
TN - Tunisia 4
UY - Uruguay 4
ET - Etiopia 3
HR - Croazia 3
IL - Israele 3
LT - Lituania 3
PE - Perù 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
LV - Lettonia 2
MK - Macedonia 2
NP - Nepal 2
RO - Romania 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ML - Mali 1
Totale 20.208
Salva come PNG Salva come JPEG
Città #
Moscow 2.141
Dublin 1.012
San Jose 747
Jacksonville 746
Chandler 718
Singapore 690
Santa Clara 621
Hong Kong 609
Bengaluru 246
Ashburn 239
Ann Arbor 206
Seoul 186
Beijing 164
Ho Chi Minh City 161
Princeton 144
Hefei 143
Naples 137
Caserta 129
Hanoi 115
Boardman 109
Medford 109
Roxbury 88
Istanbul 83
Wilmington 82
Bremen 75
Los Angeles 74
Woodbridge 73
Dallas 68
San Mateo 60
The Dalles 49
Brussels 44
Nanjing 44
São Paulo 42
Helsinki 40
Cambridge 37
New York 37
Da Nang 35
Rome 32
Houston 31
Munich 30
Aversa 29
Jinan 29
Mountain View 28
Des Moines 25
Napoli 25
Turku 25
Rio de Janeiro 23
Pozzuoli 21
Nanchang 20
Shenyang 20
Kunming 18
Norwalk 17
Orem 17
Frankfurt am Main 15
Haiphong 14
Milan 14
Tokyo 14
Frattamaggiore 13
Guangzhou 13
Afragola 12
Biên Hòa 12
Chennai 12
Council Bluffs 12
Shanghai 12
Atlanta 11
Belo Horizonte 11
Hải Dương 11
London 11
Marano 11
Memphis 11
Zhengzhou 11
Amsterdam 10
Seattle 10
Somma Vesuviana 10
Toronto 10
Vienna 10
Warsaw 10
Boston 9
Chicago 9
Hanover 9
Salerno 9
Amman 8
Columbus 8
Dhaka 8
Falkenstein 8
Thái Nguyên 8
Tianjin 8
Tricesimo 8
Denver 7
Düsseldorf 7
Giugliano in Campania 7
Hangzhou 7
Manchester 7
Phoenix 7
Tashkent 7
Viterbo 7
Volla 7
Auburn Hills 6
Cabo Frio 6
Can Tho 6
Totale 11.146
Salva come PNG Salva come JPEG
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 298
'Role of PI3-K signaling in steroid action’ 214
CROSS-TALK BETWEEN ANDROGEN RECEPTOR AND NERVE GROWTH FACTOR RECEPTOR IN PROSTATE CANCER CELLS: IMPLICATIONS FOR A NEW THERAPEUTIC APPROACH. 199
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 197
Androgen regulation of motility in fibroblasts 196
Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury. 195
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 187
Calmodulin-stimulated estradiol receptor-tyrosine kinase I 186
Breast cancer stem cells: The role of sex steroid receptors 185
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 184
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 183
Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth 181
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 180
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 180
Activation-inactivation of hormone binding sites of the oestradiol-17 beta receptor is a multiregulated process 178
Androgen-induced cell migration: role of androgen receptor/filamin A association. 178
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 174
Integrating signals between cAMP and MAPK pathways in breast cancer 172
Crosstalk between EGFR and extranuclear steroid receptors. 171
Sex steroid hormones act as growth factors 170
Protein tyrosine phosphorylation and estradiol action 169
Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/src association 169
Targeting rapid action of sex-steroid receptors in breast and prostate cancers. 168
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 167
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor a alpha tyrosine-phosphorylated peptide 166
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 166
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells through AR/Src/PI3-K Complex Assembly. 165
Agri-Food By-Products in Cancer: New Targets and Strategies. 164
Epigenetic drugs against cancer: an evolving landscape. 164
'Steroid-activated PI3-K pathway in target cells'. 163
Advances in Rapid Sex-Steroid Action New Challenges and New Chances in Breast and Prostate Cancers 163
Action of vanadate on estrogen dependent MCF-7 cells. 162
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 161
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 159
THE DUAL ROLE OF ANDROGEN RECEPTOR IN MESENCHYMAL CELLS. 158
Rapid signalling pathway activation by androgens in epithelial and stromal cells 158
Analysis of histone posttranslational modifications in the control of chromatin plasticity observed at estrogen-responsive sites in human breast cancer cells. 158
Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor β. 157
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 156
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 155
Phosphoinositide 3-kinase assay in breast cancer cell extracts. 151
EXTRA-NUCLEAR PARTNERS OF ANDROGEN RECEPTOR: AT THE CROSSROADS OF PROLIFERATION, MIGRATION AND NEURITOGENESIS. 151
Src is an initial target of sex steroid hormone action. 150
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 150
Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA. 149
In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor 149
Cell proliferation regulated by estradiol receptor: therapeutic implications. 149
ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities 149
Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding 148
Communication between cells: exosomes as a delivery system in prostate cancer. 148
The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment. 147
Binary switch between adjacent marks in histone H3 directs productive transcription in estrogen-induced breast cancer cells upon cyclical creation of ROS. 147
Role of the Androgen Receptor in Gender-Related Cancers. 146
Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. 145
A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells 144
The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions. 143
Androgens as the “old age stick” in skeletal muscle (Correction: Androgens as the “old age stick” in skeletal muscle) 141
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition 141
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 139
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 139
Steroid signaling activation and intracellular localization of sex steroid receptors 138
Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence 137
Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines. 137
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 137
Prostate cancer stem cells: the role of androgen and estrogen receptors. 135
Phosphorylation on tyrosine of oestradiol-17 beta receptor in uterus and interaction of oestradiol-17 beta and glucocorticoid receptors with antiphosphotyrosine antibodies 133
The androgen receptor in breast cancer 132
Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness. 131
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 130
Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells. 130
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 128
New insights and emerging therapeutic approaches in prostate cancer. 128
Filamin A in triple negative breast cancer. 127
Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance 126
The role of androgen receptor/filamin A association in androgen-induced cell migration 126
THE ROLE OF THE ANDROGEN RECEPTOR IN SKELETAL MUSCLE SENESCENCE. 124
The role of androgen receptor in stromal cells. 124
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 124
Novel aspects of signalling activation by steroid hormones in target cells. 124
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells. 123
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. 123
Non-genomic action of steroid hormones: More questions than answers 122
Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells 122
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 121
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 121
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells 120
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 120
Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens 118
Phosphorylation of uterus estradiol receptor on tyrosine 117
Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. 117
Protein tyrosine phosphorylation and estradiol action 115
P491 THE ANDROGEN RECEPTOR IN HUMAN SKELETAL MUSCLE BIOPSIES 115
Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells 113
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. 113
Steroid activation of signal transducing pathways. 113
NON-GENOMIC ANDROGEN ACTION REGULATES PROLIFERATIVE/MIGRATORY SIGNALLING IN STROMAL CELLS. 112
Therapeutic potential of TRPM8 antagonists in prostate cancer. 112
Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17 beta receptor. Role of Ca2+-calmodulin in the activation of hormone binding sites 110
The androgen receptor/filamin A complex as a target in prostate cancer microenvironment. 110
The role of androgen receptor/filamin A association in androgen-induced cell migration. 107
Totale 14.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.394
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/20221.042 71 11 13 30 341 36 27 28 33 91 88 273
2022/20232.338 161 67 36 243 230 234 10 174 1.047 25 60 51
2023/2024967 102 40 29 62 279 51 47 55 13 50 101 138
2024/20252.514 18 25 33 142 381 344 411 185 314 288 199 174
2025/202610.481 468 702 457 409 839 5.506 614 527 446 266 148 99
Totale 20.618